JP2006241148A - Collagenase inhibitor and external preparation for skin for preventing aging - Google Patents
Collagenase inhibitor and external preparation for skin for preventing aging Download PDFInfo
- Publication number
- JP2006241148A JP2006241148A JP2006027930A JP2006027930A JP2006241148A JP 2006241148 A JP2006241148 A JP 2006241148A JP 2006027930 A JP2006027930 A JP 2006027930A JP 2006027930 A JP2006027930 A JP 2006027930A JP 2006241148 A JP2006241148 A JP 2006241148A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- extract
- collagenase
- external preparation
- fruit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
本発明はイザヨイバラ果実の抽出物を利用したコラゲナーゼ阻害剤、及びそれを用いた老化防止用皮膚外用剤に関する。 The present invention relates to a collagenase inhibitor using an extract of Isaiyoibara fruit, and a skin external preparation for preventing aging using the same.
加齢に伴い発生するしわやたるみを予防・改善することは、美容上の重要な課題である。しわやたるみは日光に曝される部分に著しく、日光に曝された皮膚にしわやたるみが発生する現象を特に光老化と呼んでいる。光老化したしわ部分では、真皮中のコラーゲン量が著しく減少していることが知られている。一方、コラーゲンは真皮マトリックスの90%以上を占め、紫外線によって活性化されるコラゲナーゼによって分解が亢進されることも知られている。これらのことから、皮膚中のコラーゲンの減少が、皮膚のしわやたるみを引き起す主な原因であると考えられている。従って、コラーゲンの減少を抑制し得る剤を提供できれば、光老化のみならず、加齢に伴うしわやたるみを予防・改善することができる。 Prevention and improvement of wrinkles and sagging that occur with aging is an important cosmetic issue. Wrinkles and sagging are remarkable in areas exposed to sunlight, and the phenomenon in which wrinkles and sagging occur in the skin exposed to sunlight is called photoaging. It is known that the amount of collagen in the dermis is remarkably reduced in photoaged wrinkles. On the other hand, collagen accounts for 90% or more of the dermal matrix, and it is also known that degradation is enhanced by collagenase activated by ultraviolet rays. From these facts, it is considered that the reduction of collagen in the skin is the main cause of wrinkling and sagging of the skin. Therefore, if an agent capable of suppressing the decrease in collagen can be provided, not only photoaging but also wrinkles and sagging associated with aging can be prevented and improved.
一方、皮膚外用剤の有効成分として、天然物由来の成分が種々提案されている。例えば、イザヨイバラの抽出物を含有する皮膚外用剤が提案されている(特許文献1〜3参照)。しかし、イザヨイバラの抽出物とコラーゲンやコラゲナーゼとの関連性については記載がない。 On the other hand, various components derived from natural products have been proposed as active ingredients for external preparations for skin. For example, a skin external preparation containing an extract of Isaiyobara has been proposed (see Patent Documents 1 to 3). However, there is no description about the relationship between the extract of Izayoi rose and collagen or collagenase.
本発明は、コラゲナーゼの作用による生体内で生じるコラーゲン等のマトリックス線維の加水分解を防止することにより、コラーゲンの減少を有効に防止して皮膚の老化症状の進行、特に皮膚のしわ及びたるみ、を防ぐことのできるコラゲナーゼ阻害剤及び皮膚外用剤を提供することを課題とする。 The present invention effectively prevents the decrease of collagen by preventing hydrolysis of matrix fibers such as collagen generated in vivo by the action of collagenase, thereby preventing the progression of skin aging symptoms, particularly wrinkles and sagging of the skin. It is an object to provide a collagenase inhibitor and an external preparation for skin that can be prevented.
上記の課題を解決するため、本発明者は安全性が高く、しかも高活性のコラゲナーゼ阻害剤のスクリーニングを行った。その結果、イザヨイバラ果実の抽出物に優れたコラゲナーゼ阻害活性を見出し、これを皮膚外用剤に含有させることによって、皮膚の老化症状の軽減及び進行防止が認められた。 In order to solve the above-mentioned problems, the present inventor screened a collagenase inhibitor having high safety and high activity. As a result, an excellent collagenase inhibitory activity was found in the extract of Isaiyoibara fruit, and by incorporating this into an external preparation for skin, reduction of skin aging symptoms and prevention of progression were recognized.
即ち、本発明は、前記課題を解決するため、イザヨイバラ果実の抽出物からなるコラゲナーゼ阻害剤、及びイザヨイバラ果実の抽出物をコラゲナーゼ阻害剤として含有する老化防止用皮膚外用剤を提供する。
また、別の観点から、本発明によって、イザヨイバラ果実の抽出物を適用することによって真皮細胞中のコラーゲンの減少を抑制する方法;及びイザヨイバラ果実の抽出物を適用することによってコラゲナーゼを阻害する方法;が提供される。
That is, the present invention provides a collagenase inhibitor comprising an extract of Isaiyobara fruit and an anti-aging skin external preparation containing the extract of Isaiyobara fruit as a collagenase inhibitor in order to solve the above problems.
From another point of view, according to the present invention, a method for suppressing a decrease in collagen in dermal cells by applying an extract of Isaiyobara fruit; and a method for inhibiting collagenase by applying an extract of Isaiyobara fruit; Is provided.
以下、本発明について詳細に説明する。
本発明は、イザヨイバラ果実の抽出物からなるコラゲナーゼ阻害剤に関する。本発明に使用可能なイザヨイバラ(Rosa roxburghii Traff. F. normalis Rehd. Et Wils. (Rosaceae))はバラ科の植物で、別名トゲナシとも呼ばれ、その果実はシリ(Cili)と呼ばれている。本発明で用いられるイザヨイバラ果実の抽出物は、イザヨイバラ果実に含まれるいずれの成分であってもよく、果肉、果汁、果皮等から得られる成分、又はこれらの混合物が挙げられる。なお、イザヨイバラ果実の抽出物は、「トゲナシ抽出液」として市販されていて、本発明ではかかる市販品を利用することもできる。
Hereinafter, the present invention will be described in detail.
The present invention relates to a collagenase inhibitor comprising an extract of Izayoi rose fruit. Rosa roxburghii Traff. F. normalis Rehd. Et Wils. (Rosaceae), which can be used in the present invention, is a plant belonging to the family Rosaceae, also known as Togenashi, and its fruit is called Cili. The extract of Isaiyo Ibara fruit used in the present invention may be any component contained in Izayo Ibara fruit, and examples thereof include components obtained from pulp, fruit juice, pericarp, etc., or mixtures thereof. In addition, the extract of Isaiyoibara fruit is marketed as "Togenashi extract", and such a commercial item can also be used in the present invention.
イザヨイバラ果実の抽出物の調製方法については特に制限されず、一般的な抽出方法を利用することができる。果実はそのまま抽出操作に供してもよいが、抽出効率を考えると、細切、乾燥、粉砕等の処理を行った後抽出を行うことが好ましい。例えば、所望により乾燥等の前処理をした果実を、抽出溶媒に1〜5日間浸漬することで得られる。抽出は室温又は加熱下で行われるのが一般的であり、抽出温度について特に制限はないが、一般的には0〜100℃程度が適切である。また浸漬中に液を攪拌してもよい。 The method for preparing the extract of Isaiyobara fruit is not particularly limited, and a general extraction method can be used. The fruit may be subjected to the extraction operation as it is, but considering the extraction efficiency, it is preferable to perform the extraction after processing such as shredding, drying, and grinding. For example, it can be obtained by immersing a fruit that has been pretreated such as drying as desired in an extraction solvent for 1 to 5 days. The extraction is generally performed at room temperature or under heating, and the extraction temperature is not particularly limited, but generally about 0 to 100 ° C. is appropriate. Moreover, you may stir a liquid during immersion.
抽出溶媒としては、水、ならびにメタノール、エタノール、プロパノール、イソプロパノール等の低級アルコール;1、3−ブチレングリコール、プロピレングリコール、ジプロピレングリコール、グリセリン等の多価アルコール;エチルエーテル、プロピルエーテル等のエーテル類;酢酸エチル、酢酸ブチル等のエステル類;及びアセトン、エチルメチルケトン等のケトン類;などの極性有機溶媒を用いることができ、これらより1種又は2種以上を選択して用いる。中でも水、1,3−ブチレングリコール、上記例示した低級アルコールが好ましい。また、皮膚外用剤への配合を考えて、リン酸緩衝液等を用いてもよい。 As an extraction solvent, water and lower alcohols such as methanol, ethanol, propanol and isopropanol; polyhydric alcohols such as 1,3-butylene glycol, propylene glycol, dipropylene glycol and glycerin; ethers such as ethyl ether and propyl ether Polar organic solvents such as esters such as ethyl acetate and butyl acetate; and ketones such as acetone and ethyl methyl ketone can be used, and one or more of these are selected and used. Of these, water, 1,3-butylene glycol, and the lower alcohols exemplified above are preferable. A phosphate buffer solution or the like may be used in consideration of blending into a skin external preparation.
上記方法で得られたイザヨイバラ果実の抽出物は、そのままでもコラゲナーゼ阻害剤として外用剤基剤に添加できるが、濃縮、乾固したものを水や極性溶媒に再度溶解したり、あるいは脱色、脱臭、脱塩等の精製処理を行った後に添加しても良い。また保存のためには、精製処理の後、凍結乾燥し、使用時に溶媒に溶解させてもよい。 The extract of Isaiyobara fruit obtained by the above method can be added to a topical preparation base as it is as a collagenase inhibitor, but the concentrated and dried solid can be dissolved again in water or a polar solvent, or decolorized, deodorized, It may be added after a purification treatment such as desalting. For storage, it may be lyophilized after purification and dissolved in a solvent at the time of use.
本発明のコラゲナーゼ阻害剤の皮膚外用剤への配合量は、イザヨイバラ果実を十分浸漬し得る量の溶媒にて抽出して得た粗抽出物の状態で、0.001〜10.0質量%程度とするのが適当である。 The blending amount of the collagenase inhibitor of the present invention in the external preparation for skin is about 0.001 to 10.0% by mass in the state of a crude extract obtained by extracting with a solvent capable of sufficiently immersing Isaiyobara fruit. Is appropriate.
さらに本発明に係る皮膚外用剤には、活性酸素消去剤、抗炎症剤、美白剤、皮膚細胞賦活剤、殺菌剤の他、油類、界面活性剤、保湿剤、紫外線吸収剤、粉体、香料、防腐剤等、一般的な外用剤及び化粧料原料をも含有させることができる。 Furthermore, the external preparation for skin according to the present invention includes active oxygen scavengers, anti-inflammatory agents, whitening agents, skin cell activators, bactericides, oils, surfactants, moisturizers, ultraviolet absorbers, powders, General external preparations such as fragrances and preservatives and cosmetic raw materials can also be contained.
本発明に係る皮膚外用剤は、液状、ゲル状、クリーム状又は粉末状の形態で提供することができる。また本発明に係る皮膚外用剤は、ローション剤、乳剤、ゲル剤、クリーム剤、軟膏等の剤型で提供することができ、さらに化粧水、乳液、クリーム、パック等の皮膚化粧料、メイクアップベースローション、メイクアップベースクリーム、液状又はクリーム状或いは軟膏型のファンデーションといったメイクアップ化粧料、ハンドクリーム、レッグクリーム、ボディローション等の身体用化粧料などとしても提供することができる。 The external preparation for skin according to the present invention can be provided in the form of liquid, gel, cream or powder. Further, the external preparation for skin according to the present invention can be provided in a dosage form such as a lotion, emulsion, gel, cream, ointment and the like, and also a skin cosmetic such as lotion, emulsion, cream, pack, and makeup. It can also be provided as makeup cosmetics such as base lotions, makeup base creams, liquid or cream-like or ointment-type foundations, and body cosmetics such as hand creams, leg creams and body lotions.
以下に実施例を挙げて本発明をさらに具体的に説明するが、本発明の範囲は下記の実施例に限定されることはない。
[実施例1:コラゲナーゼ阻害効果の評価]
下記(1)〜(6)を準備した。なお、下記(1)〜(4)は、I型コラゲナーゼ活性測定キット(ヤガイ社製)を用いた。
(1)I型コラゲナーゼ(ヒト細胞由来、0.5unit/mL)100μL(0.3〜0.5unit/mL)
(2)蛍光(フルオレセインイソチオシアネート)標識I型コラーゲン溶液1μg/μL 45μL
(3)0.1mol/Lのトリス−塩酸緩衝液(pH7.5) 50μL
(4)酵素反応停止剤(o−フェナントロリンを含む0.05mol/Lのトリス−塩酸緩衝液(pH9.5)とエタノールの混合液)200μL
(5)イザヨイバラ果実の抽出物溶液(1,3−ブチレングリコール50%水溶液、丸善製薬社製) 乾燥固形分2%
(6)1,3−ブチレングリコール50%水溶液
The present invention will be described more specifically with reference to the following examples. However, the scope of the present invention is not limited to the following examples.
[Example 1: Evaluation of collagenase inhibitory effect]
The following (1) to (6) were prepared. In the following (1) to (4), a type I collagenase activity measurement kit (manufactured by Yagai Co., Ltd.) was used.
(1) Type I collagenase (derived from human cells, 0.5 unit / mL) 100 μL (0.3 to 0.5 unit / mL)
(2) Fluorescent (fluorescein isothiocyanate) labeled type I collagen solution 1 μg / μL 45 μL
(3) 0.1 mol / L Tris-HCl buffer (pH 7.5) 50 μL
(4) Enzyme reaction terminator (mixture of 0.05 mol / L Tris-HCl buffer (pH 9.5) and ethanol containing o-phenanthroline) 200 μL
(5) Isaiyo Ibara Fruit Extract Solution (1,3-butylene glycol 50% aqueous solution, manufactured by Maruzen Pharmaceutical Co., Ltd.) Dry solid content 2%
(6) 1,3-butylene glycol 50% aqueous solution
まず、上記の(1)〜(3)、(5)及び(6)を混合して、37℃で3時間加熱後、(4)の酵素反応停止剤を添加した。(5)の量は、目的の固形分濃度に応じて決定した。(6)は(5)との合計が5μLになるように添加した。次に、溶液を遠心分離して未反応のコラーゲンを沈殿させ、コラゲナーゼの分解活性により蛍光標識がはずれた上清を採取して蛍光強度を測定した。蛍光強度は蛍光分光光度計を用い(励起光495nm、蛍光強度520nm)、試料添加及び試料無添加における吸光度Er及びEsをそれぞれ測定した。さらに、コラゲナーゼを用いずに(即ち(1)を混合しないで)、同じ操作を行った際の吸光度Ebr及びEbsをそれぞれ測定した。これらの測定値を下記数式に代入してコラゲナーゼ阻害率(%)を算出した。また、参考例として、コラゲナーゼ阻害作用が知られているエチレンジアミン四酢酸(EDTA)について、同様に試験を行った。
コラゲナーゼ阻害率(%)
=[{(Es−Ebs)−(Er−Ebr)}/(Es−Ebs)]×100
結果を下記表1に併せて示す。
First, the above (1) to (3), (5) and (6) were mixed, heated at 37 ° C. for 3 hours, and then the enzyme reaction terminator (4) was added. The amount of (5) was determined according to the target solid content concentration. (6) was added so that the total with (5) was 5 μL. Next, the solution was centrifuged to precipitate unreacted collagen, and the supernatant from which the fluorescent label was removed due to the degradation activity of collagenase was collected and the fluorescence intensity was measured. The fluorescence intensity was measured using a fluorescence spectrophotometer (excitation light 495 nm, fluorescence intensity 520 nm), and the absorbances Er and Es with and without the sample added were measured, respectively. Furthermore, the absorbances Ebr and Ebs when the same operation was performed without using collagenase (that is, without mixing (1)) were measured. These measured values were substituted into the following mathematical formula to calculate the collagenase inhibition rate (%). Further, as a reference example, ethylenediaminetetraacetic acid (EDTA), which is known to have a collagenase inhibitory action, was similarly tested.
Collagenase inhibition rate (%)
= [{(Es−Ebs) − (Er−Ebr)} / (Es−Ebs)] × 100
The results are also shown in Table 1 below.
表1の結果より、イザヨイバラ果実の抽出物には、既にコラゲナーゼ阻害効果が知れられているエチレンジアミン四酢酸(EDTA)と同等もしくはそれ以上のコラゲナーゼ阻害効果があることが明らかである。 From the results in Table 1, it is clear that the extract of Isaiyobara fruit has a collagenase inhibitory effect equal to or higher than that of ethylenediaminetetraacetic acid (EDTA), which is already known to have a collagenase inhibitory effect.
[実施例2:化粧水の調製]
(成分) (%)
(1)グリセリン 10.0
(2)1,3−ブチレングリコール 6.0
(3)トゲナシ抽出液*1 1.0
(4)クエン酸 0.1
(5)クエン酸ナトリウム 0.3
(6)精製水 残量
(7)ポリオキシエチレン(40E.O.)硬化ヒマシ油 0.5
(8)エチルアルコール 8.0
(9)防腐剤 適量
(10)香料 適量
*1:丸善製薬社製
[Example 2: Preparation of lotion]
(Ingredient) (%)
(1) Glycerin 10.0
(2) 1,3-butylene glycol 6.0
(3) Capsicum extract * 1 1.0
(4) Citric acid 0.1
(5) Sodium citrate 0.3
(6) Purified water remaining amount (7) polyoxyethylene (40EO) hydrogenated castor oil 0.5
(8) Ethyl alcohol 8.0
(9) Preservative appropriate amount (10) Fragrance appropriate amount * 1: Made by Maruzen Pharmaceutical Co., Ltd.
A. 成分(1)〜(6)を混合溶解した。
B. 成分(7)〜(10)を混合溶解した。
C. AとBを混合して均一にし、化粧水を得た。
A. Components (1) to (6) were mixed and dissolved.
B. Components (7) to (10) were mixed and dissolved.
C. A and B were mixed and uniformed to obtain a skin lotion.
[実施例3:乳液の調製]
(成分) (%)
(1)新油型モノステアリン酸グリセリル 0.3
(2)ステアリン酸 0.5
(3)セトステアリルアルコール 0.5
(4)スクワラン 3.0
(5)流動パラフィン 5.0
(6)トリ2−エチルヘキサン酸グリセリル 2.0
(7)防腐剤 適量
(8)カルボキシビニルポリマー 0.1
(9)精製水 残量
(10)水酸化ナトリウム 0.05
(11)グリセリン 10.0
(12)トゲナシ抽出物*1 0.01
(13)茶抽出物*2 0.01
(14)リン酸−L−アスコルビルマグネシウム*3 0.01
(15)香料 適量
*1:丸善製薬社製
*2:新日本薬業社製
*3:日光ケミカルズ社製
[Example 3: Preparation of emulsion]
(Ingredient) (%)
(1) New oil type glyceryl monostearate 0.3
(2) Stearic acid 0.5
(3) cetostearyl alcohol 0.5
(4) Squalane 3.0
(5) Liquid paraffin 5.0
(6) Glyceryl tri-2-ethylhexanoate 2.0
(7) Preservative appropriate amount (8) Carboxyvinyl polymer 0.1
(9) Purified water remaining amount (10) Sodium hydroxide 0.05
(11) Glycerin 10.0
(12) Capsicum extract * 1 0.01
(13) Tea extract * 2 0.01
(14) Phosphoric acid-L-ascorbyl magnesium * 3 0.01
(15) Perfume appropriate amount * 1: Maruzen Pharmaceutical * 2: Shin Nippon Pharmaceutical Co., Ltd. * 3: Nikko Chemicals
(製法)
A.成分(8)〜(11)を加熱混合し、70℃に維持した。
B.成分(1)〜(7)を加熱混合し、70℃に維持した。
C.AとBを混合し、均一に乳化した。
D.Cを冷却後、(12)〜(15)を加え、均一に混合して乳液を得た。
(Manufacturing method)
A. Components (8) to (11) were mixed by heating and maintained at 70 ° C.
B. Components (1) to (7) were mixed by heating and maintained at 70 ° C.
C. A and B were mixed and uniformly emulsified.
D. After cooling C, (12) to (15) were added and mixed uniformly to obtain an emulsion.
[実施例4:美容液の調製]
(成分) (%)
(1)コレステロール 0.5
(2)水素添加大豆リン脂質 2.0
(3)グリセリン 10.0
(4)1,3−ブチレングリコール 5.0
(5)ジメチルポリシロキサン 1.0
(6)ワセリン 1.0
(7)防腐剤 適量
(8)アルキル変性カルボキシビニルポリマー 0.2
(9)水酸化ナトリウム 0.08
(10)精製水 残量
(11)トゲナシ抽出物*1 2.0
(12)ヨクイニン抽出物*2 0.5
(13)メロスリア抽出物*3 0.5
(14)L−セリン 0.5
*1:丸善製薬社製
*2:丸善製薬社製
*3:丸善製薬社製
[Example 4: Preparation of serum]
(Ingredient) (%)
(1) Cholesterol 0.5
(2) Hydrogenated soybean phospholipid 2.0
(3) Glycerin 10.0
(4) 1,3-butylene glycol 5.0
(5) Dimethylpolysiloxane 1.0
(6) Vaseline 1.0
(7) Preservative appropriate amount (8) Alkyl-modified carboxyvinyl polymer 0.2
(9) Sodium hydroxide 0.08
(10) Purified water remaining amount (11) Capsicum extract * 1 2.0
(12) Yokuinin extract * 2 0.5
(13) Melosria extract * 3 0.5
(14) L-serine 0.5
* 1: Maruzen Pharmaceutical * 2: Maruzen Pharmaceutical * 3: Maruzen Pharmaceutical
(製法)
A.成分(1)〜(7)を加熱混合し、70℃に維持した。
B.成分(8)〜(10)を加熱混合し、70℃に維持した。
C.AとBとを混合し、均一に乳化した。
D.Cを冷却後(11)〜(14)を加え、均一に混合して乳液を得た。
(Manufacturing method)
A. Components (1) to (7) were mixed by heating and maintained at 70 ° C.
B. Components (8) to (10) were heated and mixed and maintained at 70 ° C.
C. A and B were mixed and uniformly emulsified.
D. After cooling C, (11) to (14) were added and mixed uniformly to obtain an emulsion.
[実施例5:クリームの調製]
(成分) (%)
(1)モノステアリン酸ソルビタン 0.3
(2)セトステアリルアルコール 3.0
(3)スクワラン 5.0
(4)ワセリン 3.0
(5)トリ2−エチルへキサン酸グリセリル 3.0
(6)防腐剤 適量
(7)N−ステアロイルグルタミン酸ナトリウム 0.5
(8)キサンタンガム 0.05
(9)カルボキシビニルポリマー 0.1
(10)精製水 残量
(11)水酸化ナトリウム 0.03
(12)グリセリン 10.0
(13)ジプロピレングリコール 3.0
(14)トゲナシ抽出物*1 0.01
(15)茶抽出物*2 0.01
(16)リン酸−L−アスコルビルマグネシウム*3 0.01
(17)香料 適量
*1:丸善製薬社製
*2:新日本薬業社製
*3:日光ケミカルズ社製
[Example 5: Preparation of cream]
(Ingredient) (%)
(1) Sorbitan monostearate 0.3
(2) Cetostearyl alcohol 3.0
(3) Squalane 5.0
(4) Vaseline 3.0
(5) Glyceryl tri-2-ethylhexanoate 3.0
(6) Preservative appropriate amount (7) Sodium N-stearoyl glutamate 0.5
(8) Xanthan gum 0.05
(9) Carboxyvinyl polymer 0.1
(10) Purified water remaining amount (11) Sodium hydroxide 0.03
(12) Glycerin 10.0
(13) Dipropylene glycol 3.0
(14) Capsicum extract * 1 0.01
(15) Tea extract * 2 0.01
(16) Phosphate-L-ascorbyl magnesium * 3 0.01
(17) Fragrance Appropriate amount * 1: Made by Maruzen Pharmaceutical * 2: Shin Nippon Pharmaceutical Co., Ltd. * 3: Nikko Chemicals
(製法)
A.成分(8)〜(13)を加熱混合し、70℃に維持した。
B.成分(1)〜(7)を加熱混合し、70℃に維持した。
C.AとBを混合し、均一に乳化した。
D.Cを冷却後、(14)〜(17)を加え、均一に混合して乳液を得た。
(Manufacturing method)
A. Components (8) to (13) were mixed by heating and maintained at 70 ° C.
B. Components (1) to (7) were mixed by heating and maintained at 70 ° C.
C. A and B were mixed and uniformly emulsified.
D. After cooling C, (14) to (17) were added and mixed uniformly to obtain an emulsion.
[実施例6:含浸パックの調製]
(成分) (%)
(1)エチルアルコール 6.0
(2)ポリオキシエチレン(40E.O.)硬化ヒマシ油 0.5
(3)香料 適量
(4)乳酸ナトリウム液(50%) 0.5
(5)乳酸 0.02
(6)防腐剤 適量
(7)精製水 残量
(8)グリセリン 8.0
(9)トゲナシ抽出物*1 0.02
(10)水溶性コラーゲン液*2 2.0
(11)ヒアルロン酸液*3 3.0
*1:丸善製薬社製
*2:片倉チッカリン社製
*3:日光ケミカルズ社製
[Example 6: Preparation of impregnation pack]
(Ingredient) (%)
(1) Ethyl alcohol 6.0
(2) Polyoxyethylene (40E.O.) hydrogenated castor oil 0.5
(3) Perfume appropriate amount (4) Sodium lactate solution (50%) 0.5
(5) Lactic acid 0.02
(6) Preservative appropriate amount (7) Purified water remaining amount (8) Glycerin 8.0
(9) Capsicum extract * 1 0.02
(10) Water-soluble collagen solution * 2 2.0
(11) Hyaluronic acid solution * 3 3.0
* 1: Maruzen Pharmaceutical * 2: Katakura Chikkarin * 3: Nikko Chemicals
(製法)
A.成分(1)〜(3)を混合溶解した。
B.成分(4)〜(11)を混合溶解した。
C.AとBとを混合して均一にし、得られた化粧水を不織布に含有させパック化粧料を得た。
(Manufacturing method)
A. Components (1) to (3) were mixed and dissolved.
B. Components (4) to (11) were mixed and dissolved.
C. A and B were mixed and made uniform, and the obtained lotion was contained in a nonwoven fabric to obtain a pack cosmetic.
[実施例7:マッサージジェルの調製]
(成分) (%)
(1)グリセリン 10.0
(2)エチルアルコール 0.5
(3)トゲナシ抽出物*1 1.0
(4)ドクダミ抽出物*2 0.5
(5)ユキノシタ抽出物*3 0.1
(6)精製水 残量
(7)ヒドロキシメチルセルロース 0.1
(8)カルボキシビニルポリマー 0.1
(9)水酸化ナトリウム 0.04
(10)ジメチルポリシロキサン 0.1
(11)ポリオキシアルキレン変性オルガノポリシロキサン 0.1
(12)香料 適量
*1:丸善製薬社製
*2:一丸ファルコス社製
*3:一丸ファルコス社製
[Example 7: Preparation of massage gel]
(Ingredient) (%)
(1) Glycerin 10.0
(2) Ethyl alcohol 0.5
(3) Capsicum extract * 1 1.0
(4) Dokudami extract * 2 0.5
(5) Yukinoshita extract * 3 0.1
(6) Purified water remaining amount (7) Hydroxymethylcellulose 0.1
(8) Carboxyvinyl polymer 0.1
(9) Sodium hydroxide 0.04
(10) Dimethylpolysiloxane 0.1
(11) Polyoxyalkylene-modified organopolysiloxane 0.1
(12) Perfume appropriate amount * 1: Made by Maruzen Pharmaceutical * 2: Made by Ichimaru Falcos * 3: Made by Ichimaru Falcos
(製法)
A.成分(1)〜(9)を混合溶解した。
B.成分(10)〜(12)を混合溶解した。
C.AとBとを混合して均一にし、マッサージジェルを得た。
(Manufacturing method)
A. Components (1) to (9) were mixed and dissolved.
B. Components (10) to (12) were mixed and dissolved.
C. A and B were mixed and uniformed to obtain a massage gel.
実施例2〜7で調製した種々のタイプの皮膚外用剤は、いずれも皮膚に適用することにより、肌をみずみずしく保ち、しわやたるみの防止・改善に寄与する剤であった。また、いずれの剤も成分による変色・変臭などの問題は生じていなかった。 Various types of external preparations for skin prepared in Examples 2 to 7 were all agents applied to the skin to keep the skin fresh and contribute to prevention and improvement of wrinkles and sagging. In addition, none of the agents caused problems such as discoloration or odor change due to the components.
本発明に用いるイザヨイバラ果実の抽出物は、優れたコラゲナーゼ阻害作用を示し、且つ安全性にも優れた成分である。従って、化粧料、医薬部外品、医薬品等の皮膚外用剤のための幅広い製剤への配合が可能である。本発明の皮膚外用剤は、イザヨイバラ果実の抽出物を含有しているので、皮膚の老化防止効果に優れ、老化によって生じるしわやたるみを防止又は改善することができる。 The extract of Isaiyoibara fruit used in the present invention is a component that exhibits an excellent collagenase inhibitory action and is also excellent in safety. Therefore, it can be blended into a wide range of preparations for external preparations for skin such as cosmetics, quasi drugs and pharmaceuticals. Since the skin external preparation of the present invention contains an extract of Izayoi rose fruit, it is excellent in the effect of preventing skin aging and can prevent or improve wrinkles and sagging caused by aging.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006027930A JP2006241148A (en) | 2005-02-07 | 2006-02-06 | Collagenase inhibitor and external preparation for skin for preventing aging |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005030217 | 2005-02-07 | ||
JP2006027930A JP2006241148A (en) | 2005-02-07 | 2006-02-06 | Collagenase inhibitor and external preparation for skin for preventing aging |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2006241148A true JP2006241148A (en) | 2006-09-14 |
Family
ID=37047903
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006027930A Pending JP2006241148A (en) | 2005-02-07 | 2006-02-06 | Collagenase inhibitor and external preparation for skin for preventing aging |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2006241148A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102099049A (en) * | 2008-05-30 | 2011-06-15 | 戴纳米斯制药公司 | Methods for treating progressive cognitive disorders related to neurofibrillary tangles |
JP2012148988A (en) * | 2011-01-18 | 2012-08-09 | Nippon Menaade Keshohin Kk | External preparation or internal preparation |
WO2012124738A1 (en) | 2011-03-15 | 2012-09-20 | 株式会社資生堂 | Bleomycin hydrolase production promoting agent |
JP2013018715A (en) * | 2011-07-07 | 2013-01-31 | Kao Corp | Mfap-4 production promoter |
JP2016056205A (en) * | 2016-01-14 | 2016-04-21 | 花王株式会社 | Mfap-4 production promoter |
EP3572089A1 (en) * | 2018-05-25 | 2019-11-27 | NuLiv Science USA, Inc. | Anti-aging method and composition |
CN116035151A (en) * | 2023-01-18 | 2023-05-02 | 云南贝泰妮生物科技集团股份有限公司 | Rosa roxburghii flash release powder and preparation method and application thereof |
-
2006
- 2006-02-06 JP JP2006027930A patent/JP2006241148A/en active Pending
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102099049A (en) * | 2008-05-30 | 2011-06-15 | 戴纳米斯制药公司 | Methods for treating progressive cognitive disorders related to neurofibrillary tangles |
JP2012148988A (en) * | 2011-01-18 | 2012-08-09 | Nippon Menaade Keshohin Kk | External preparation or internal preparation |
WO2012124738A1 (en) | 2011-03-15 | 2012-09-20 | 株式会社資生堂 | Bleomycin hydrolase production promoting agent |
EP3498286A1 (en) | 2011-03-15 | 2019-06-19 | Shiseido Company, Ltd. | Bleomycin hydrolase production promotor |
JP2013018715A (en) * | 2011-07-07 | 2013-01-31 | Kao Corp | Mfap-4 production promoter |
JP2016056205A (en) * | 2016-01-14 | 2016-04-21 | 花王株式会社 | Mfap-4 production promoter |
EP3572089A1 (en) * | 2018-05-25 | 2019-11-27 | NuLiv Science USA, Inc. | Anti-aging method and composition |
CN110522807A (en) * | 2018-05-25 | 2019-12-03 | 仲华国际美国公司 | Anti-aging method and composition |
CN116098942A (en) * | 2018-05-25 | 2023-05-12 | 仲华国际美国公司 | Anti-aging method and composition |
CN116035151A (en) * | 2023-01-18 | 2023-05-02 | 云南贝泰妮生物科技集团股份有限公司 | Rosa roxburghii flash release powder and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4425163B2 (en) | Anti-aging cosmetics | |
JP2010006708A (en) | External preparation for skin, bleaching agent, anti-aging agent and anti-oxidizing agent | |
JP2003300858A (en) | Skin care preparation | |
JP2006241148A (en) | Collagenase inhibitor and external preparation for skin for preventing aging | |
JP2003113068A (en) | Skin cosmetic | |
JP2024036484A (en) | Cosmetic composition containing graphene quantum dot as active ingredient | |
KR102415369B1 (en) | Functional bath cleanser composition comprising plant powder | |
JP4921732B2 (en) | Melanin synthesis promoter and topical skin preparation | |
JP2001342112A (en) | Skin care preparation | |
JP2004231558A (en) | External preparation for skin for bleaching | |
JP2006273823A (en) | Moisturizing and antiaging cosmetic | |
JP2008184441A (en) | External preparation for skin for promoting fibroblast proliferation | |
JP2006151831A (en) | Antioxidant, dna damage inhibitor or skin care preparation | |
JP2011195539A (en) | Elastase activity inhibitor | |
JP2010150173A (en) | Skin whitening agent, melanogenesis inhibitor, and skin whitening skin external preparation | |
JP2008255043A (en) | Skincare preparation for external use | |
JP2006316029A (en) | Endothelin-1 production inhibitor and melanin production inhibitor | |
JP2006199611A (en) | Cosmetic | |
JP2013107859A (en) | Skin cosmetic preparation for external use comprising connarus extract | |
JP6723979B2 (en) | Wrinkle improver | |
JP2009234976A (en) | Cell activator and external preparation for skin for antiaging | |
JP2009249366A (en) | Collagen production promotor and anti-aging skin preparation for external use | |
JP6253702B2 (en) | Cosmetics for external use with Connals louver extract | |
JP2009269842A (en) | External preparation for skin | |
JP2015093848A (en) | Skin cosmetic and hair cosmetic |